Brennan Edward J. reported grant involving 14,534 shares of Medicus Pharma Ltd. at $1.72 for $25.0k on Nov 13, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SVP, Medical Affairs
SVP, Medical Affairs
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$24,998.48Shares × reported price
Shares traded
14,534Common Shares, no par value
Price per share
$1.72Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
28,029Direct
Trade date
Nov 13, 2026Grant
Filed
Nov 17, 2026, 5:06 PM ET4-day reporting delay
Accession
0000950142-26-003105Code A · Transaction 404092
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MDCX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MDCX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: On November 13, 2026, Edward J. Brennan entered into a subscription agreement with the Issuer, pursuant to which Mr. Brennan agreed to purchase 14,534 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.